TAIM
ROIV icon

Te Ahumairangi Investment Management’s Roivant Sciences ROIV Stock Holding History

Te Ahumairangi Investment Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.6M Sell
73,367
-19,300
-21% -$570K 0.42% 74
2026
Q1 		$2.57M Sell
92,667
-15,740
-15% -$404K 0.43% 71
2025
Q4 		$2.35M Sell
108,407
-54,800
-34% -$1.08M 0.42% 75
2025
Q3 		$2.47M Sell
163,207
-13,604
-8% -$168K 0.42% 74
2025
Q2 		$1.99M Buy
176,811
+18,800
+12% +$204K 0.36% 79
2025
Q1 		$1.59M Hold
158,011
– – 0.34% 76
2024
Q4 		$1.87M Sell
158,011
-43,601
-22% -$515K 0.39% 72
2024
Q3 		$2.31M Buy
201,612
+33,467
+20% +$381K 0.41% 74
2024
Q2 		$1.78M Sell
168,145
-22,500
-12% -$247K 0.34% 75
2024
Q1 		$2.01M Buy
190,645
+32,600
+21% +$352K 0.35% 76
2023
Q4 		$1.77M Buy
+158,045
New +$1.54M 0.34% 77

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Te Ahumairangi Investment Management's ROIV Position: Q2 2026 in Review

Te Ahumairangi Investment Management reduced its Roivant Sciences (ROIV) stake by 21% in Q2 2026, selling an estimated $570K and leaving 73,367 shares worth $2.6M. The position accounts for 0.42% of the portfolio, ranked #74.

Te Ahumairangi Investment Management first reported a position in ROIV in Q4 2023 and has held it in 11 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Te Ahumairangi Investment Management held 73,367 shares of Roivant Sciences worth $2.6M as of Q2 2026.
  • Te Ahumairangi Investment Management sold 19,300 Roivant Sciences shares in Q2 2026, an estimated $570K.
  • Roivant Sciences made up 0.42% of Te Ahumairangi Investment Management's portfolio in Q2 2026, its #74 holding.
  • Te Ahumairangi Investment Management first reported a position in Roivant Sciences in Q4 2023 and has held it in 11 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Te Ahumairangi Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.